Azab Mohammad
- SEC CIK
- 0001309653
No open-market purchases or sales filed in the past year.
Current role at each company
- LSTA Lisata Therapeutics, Inc.Directoras of Jan 13, 2026
- DRRX Durect CorpDirectoras of Sep 12, 2025
- XENE Xenon Pharmaceuticals Inc.Directoras of Dec 20, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Azab Mohammad as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
DRRX Durect Corp
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 25, 2022 (view filing)8:03 PM ET | May 24 | 1 day | Azab MohammadDirector | PPurchase | +30.0K | $0.3879 | +$11.6K | +100.0%60.0K after | 5 lots |
| May 18, 2022 (view filing)8:05 PM ET | May 16-17 | 2 days | Azab MohammadDirector | PPurchase | +30.0K | $0.4058 | +$12.2K | New position30.0K after | 4 lots |